{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:53:36Z","timestamp":1790358816585,"version":"4.1.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","award":["A0X 816"],"award-info":[{"award-number":["A0X 816"]}],"id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","award":["A0X 816"],"award-info":[{"award-number":["A0X 816"]}],"id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04833-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T06:56:55Z","timestamp":1748329015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization and stratification of risk factors of stroke in people living with HIV: A theory-informed systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Martins","family":"Nweke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nombeko","family":"Mshunqane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"5","key":"4833_CR1","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","volume":"10","author":"A Trickey","year":"2023","unstructured":"Trickey A, Sabin CA, Burkholder G, Crane H, d\u2019Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, Lampe FC, Obel N, Reyes JM, Stephan C, Sterling TR, Teira R, Touloumi G, Wasmuth JC, Wit F, Wittkop L, Zangerle R, Silverberg MJ, Justice A, Sterne JAC. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295\u2013307.","journal-title":"Lancet HIV"},{"issue":"1","key":"4833_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.122.057443","volume":"147","author":"HIV Living With","year":"2023","unstructured":"Living With HIV. New Insights into Pathogenesis and Clinical Manifestations in a Global Context. Circulation. 2023;147(1):83\u2013100.","journal-title":"Circulation"},{"key":"4833_CR3","unstructured":"American Health Association. 2019. As HIV patients live longer, heart disease might be their next challenge. https:\/\/www.heart.org\/en\/news\/2019\/06\/03\/as-hiv-patients-live-longer-heart-disease-might-be-their-next-challenge."},{"issue":"8","key":"4833_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jchf.2015.05.003","volume":"3","author":"GS Bloomfield","year":"2015","unstructured":"Bloomfield GS, Alenezi F, Barasa FA, Lumsden R, Mayosi BM, Velazquez EJ. Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries. JACC Heart Fail. 2015;3(8):579\u201390.","journal-title":"JACC Heart Fail"},{"issue":"8","key":"4833_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archinternmed.2011.151","volume":"171","author":"AA Butt","year":"2011","unstructured":"Butt AA, Chang CC, Kuller L, et al. Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med. 2011;171(8):737\u201343.","journal-title":"Arch Intern Med"},{"issue":"1","key":"4833_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/QAI.0000000000002629","volume":"87","author":"Y Chen","year":"2021","unstructured":"Chen Y, Gao Y, Zhou Y, Li X, Wang H, Polonsky TS, Vermund SH, Qian HZ, Qian F. Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies. J Acquir Immune Defic Syndr. 2021;87(1):741\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000002629PMCID:PMC10768809.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4833_CR7","doi-asserted-by":"publisher","first-page":"H731","DOI":"10.1152\/ajpheart.00549.2019","volume":"318","author":"L Dominick","year":"2020","unstructured":"Dominick L, Midgley N, Swart LM, Sprake D, Deshpande G, Laher I, Joseph D, Teer E, Essop MF. HIV-related cardiovascular diseases: the search for a unifying hypothesis. Am J Physiol Heart Circ Physiol. 2020;318(4):H731\u201346.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"4833_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11904-019-00458-1","volume":"16","author":"M Toribio","year":"2019","unstructured":"Toribio M, Neilan TG, Zanni MV. Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations. Curr HIV\/AIDS Rep. 2019;16(5):371\u201380. https:\/\/doi.org\/10.1007\/s11904-019-00458-1.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"4833_CR9","doi-asserted-by":"publisher","unstructured":"Sinha A, Feinstein M. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV. Prog Cardiovasc Dis. 2020;63(2):134\u2013141. https:\/\/doi.org\/10.1016\/j.pcad.2020.01.002. Epub 2020 Jan 24. PMID: 31987806; PMCID: PMC7237287.","DOI":"10.1016\/j.pcad.2020.01.002"},{"issue":"2","key":"4833_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jchf.2018.10.006","volume":"7","author":"S Erqou","year":"2019","unstructured":"Erqou S, Lodebo BT, Masri A, Altibi AM, Echouffo-Tcheugui JB, Dzudie A, Ataklte F, Choudhary G, Bloomfield GS, Wu WC, Kengne AP. Cardiac Dysfunction Among People Living With HIV: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2019;7(2):98\u2013108. https:\/\/doi.org\/10.1016\/j.jchf.2018.10.006. (PMID: 30704613).","journal-title":"JACC Heart Fail"},{"issue":"6","key":"4833_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/COH.0000000000000409","volume":"12","author":"PY Hsue","year":"2017","unstructured":"Hsue PY, Waters DD. Heart failure in persons living with HIV infection. Curr Opin HIV AIDS. 2017;12(6):534\u20139. https:\/\/doi.org\/10.1097\/COH.0000000000000409. (PMID: 28863015).","journal-title":"Curr Opin HIV AIDS"},{"issue":"17","key":"4833_CR12","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574.PMID:24778120","volume":"129","author":"J Remick","year":"2014","unstructured":"Remick J, Georgiopoulou V, Marti C, Ofotokun I, Kalogeropoulos A, Lewis W, Butler J. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation. 2014;129(17):1781\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004574.","journal-title":"Circulation"},{"issue":"9","key":"4833_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1212\/WNL.0000000000009030","volume":"94","author":"JJ Majersik","year":"2020","unstructured":"Majersik JJ, Woo D. The enormous financial impact of stroke disability. Neurology. 2020;94(9):377\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000009030.","journal-title":"Neurology"},{"key":"4833_CR14","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1186\/s12889-015-2570-z","volume":"15","author":"M Kroll","year":"2015","unstructured":"Kroll M, Phalkey RK, Kraas F. Challenges to the surveillance of non-communicable diseases \u2013 a review of selected approaches. BMC Public Health. 2015;15:1243. https:\/\/doi.org\/10.1186\/s12889-015-2570-z.","journal-title":"BMC Public Health"},{"issue":"11","key":"4833_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.amjmed.2009.04.022","volume":"122","author":"SM Dunlay","year":"2009","unstructured":"Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk factors for heart failure: a population-based case-control study. Am J Med. 2009;122(11):1023\u20138. https:\/\/doi.org\/10.1016\/j.amjmed.2009.04.022PMID:19854330;PMCID:PMC2789475.","journal-title":"Am J Med"},{"key":"4833_CR16","doi-asserted-by":"publisher","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30\u201341. https:\/\/doi.org\/10.1038\/nrcardio.2010.165. Epub 2010 Nov 9. PMID: 21060326; PMCID: PMC3033496.","DOI":"10.1038\/nrcardio.2010.165"},{"issue":"3","key":"4833_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/QAI.0000000000001917","volume":"80","author":"Y Yen","year":"2019","unstructured":"Yen Y, Ko M, Yen M-Y, Hu B, Wang T, Chuang P, Lai H, Chen C, Deng C. Human Immunodeficiency Virus Increases the Risk of Incident Heart Failure: JAIDS. J Acquir Immune Defic Syndr. 2019;80(3):255.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4833_CR18","doi-asserted-by":"crossref","unstructured":"Marconi VC, Duncan MS, So-Armah K, Lo Re V, Lim JK, Butt AA, Goetz MB, Rodriguez-Barradas MC, Alcorn CW, Lennox J et al: Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV-Positive and HIV-Negative Individuals in VACS (Veterans Aging Cohort Study). Journal of the American Heart Association 2018, 7(10).","DOI":"10.1161\/JAHA.117.007792"},{"issue":"6","key":"4833_CR19","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/jch.14255","volume":"23","author":"FS Sarfo","year":"2021","unstructured":"Sarfo FS, Norman B, Appiah L, Ovbiagele B. Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long-Term Antiretroviral Suppressive Therapy (EVERLAST) Study. J Clin Hypertens. 2021;23(6):1252\u20139.","journal-title":"J Clin Hypertens"},{"key":"4833_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0002-9343(99)00126-6","volume":"106","author":"YT Chen","year":"1999","unstructured":"Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med. 1999;106:605\u201312.","journal-title":"Am J Med"},{"issue":"6","key":"4833_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","volume":"35","author":"JS Gottdiener","year":"2000","unstructured":"Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000;35(6):1628\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4833_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa020245","volume":"347","author":"S Kenchaiah","year":"2002","unstructured":"Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305\u201313. https:\/\/doi.org\/10.1056\/NEJMoa020245. (PMID: 12151467).","journal-title":"N Engl J Med"},{"issue":"20","key":"4833_CR23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557\u201362 (PMID: 8622246).","journal-title":"JAMA"},{"issue":"7","key":"4833_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archinte.161.7.996","volume":"161","author":"J He","year":"2001","unstructured":"He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk Factors for Congestive Heart Failure in US Men and Women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med. 2001;161(7):996\u20131002. https:\/\/doi.org\/10.1001\/archinte.161.7.996.","journal-title":"Arch Intern Med"},{"issue":"10","key":"4833_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.22190","volume":"3","author":"R Khera","year":"2020","unstructured":"Khera R, Kondamudi N, Zhong L, et al. Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016. JAMA Netw Open. 2020;3(10): e2022190. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.22190.","journal-title":"JAMA Netw Open"},{"key":"4833_CR26","doi-asserted-by":"publisher","unstructured":"Feijen EAML, Font-Gonzalez A, Van der Pal HJH, Kok WEM, Geskus RB, Ronckers CM, Bresters D, van Dalen EC, van Dulmen-den Broeder E, van den Berg MH, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, van Leeuwen FE, Loonen JJ, Neggers SJCMM, Versluys ABB, Tissing WJE, Kremer LCM; DCOG\u2010LATER Study Group. Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study. J Am Heart Assoc. 2019;8(1):e009122. https:\/\/doi.org\/10.1161\/JAHA.118.009122. PMID: 30595059; PMCID: PMC6405698.","DOI":"10.1161\/JAHA.118.009122"},{"key":"4833_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246813","volume":"16","author":"NS Shah","year":"2021","unstructured":"Shah NS, Petito LC, Pool L, Lloyd-Jones DM, Feinglass J, et al. Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011\u20132018: a cross-sectional study. PLoS ONE. 2021;16: e0246813.","journal-title":"PLoS ONE"},{"issue":"4","key":"4833_CR28","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","volume":"7","author":"K So-Armah","year":"2020","unstructured":"So-Armah K, Benjamin LA, Bloomfield GS, Feinstein MJ, Hsue P, Njuguna B, Freiberg MS. HIV and cardiovascular disease. Lancet HIV. 2020;7(4):e279\u201393.","journal-title":"Lancet HIV"},{"issue":"5","key":"4833_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0000000000003382","volume":"95","author":"MHED Moawad","year":"2024","unstructured":"Moawad MHED, Mohamed Shalaby MM, Hamouda E, Mahfouz A, Mouffokes A, Hamouda H, Abbas A, Abdelgawad HAH. Risk of Stroke Among HIV Patients: A Systematic Review and Meta-analysis of Global Studies and Associated Comorbidities. J Acquir Immune Defic Syndr. 2024;95(5):399\u2013410.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4833_CR30","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.4081\/jphr.2020.1726","volume":"9","author":"AH Alrawahi","year":"2020","unstructured":"Alrawahi AH. New approaches to disease causation research based on the sufficient-component cause model. J Public Health Res. 2020;9(3):1726. https:\/\/doi.org\/10.4081\/jphr.2020.1726PMID:32953700;PMCID:PMC7482181.","journal-title":"J Public Health Res"},{"key":"4833_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijpvm.IJPVM_469_20","volume":"12","author":"S Rahimi Pordanjani","year":"2021","unstructured":"Rahimi Pordanjani S, Hasanpour A, Askarpour H, Bastam D, Rafiee M, Khazaei Z, Mazaheri E, Vaziri MH, Sabour S. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review. Int J Prev Med. 2021;12:38.","journal-title":"Int J Prev Med"},{"key":"4833_CR32","doi-asserted-by":"publisher","unstructured":"Shimonovich M, Pearce A, Thomson H, Keyes K, Katikireddi SV. Assessing causality in epidemiology: revisiting Bradford Hill to incorporate developments in causal thinking. Eur J Epidemiol. 2021;36(9):873\u2013887. https:\/\/doi.org\/10.1007\/s10654-020-00703-7. Epub 2020 Dec 16. PMID: 33324996; PMCID: PMC8206235.","DOI":"10.1007\/s10654-020-00703-7"},{"key":"4833_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-7622-2-11","volume":"2","author":"M H\u00f6fler","year":"2005","unstructured":"H\u00f6fler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol. 2005;2:11. https:\/\/doi.org\/10.1186\/1742-7622-2-11.","journal-title":"Emerg Themes Epidemiol"},{"key":"4833_CR34","doi-asserted-by":"crossref","unstructured":"Nweke, M., Oyirinnaya, P., Nwoha, P., Mitha, S., Mshunqane, N., Govender, N. and Ukwuoma, M., 2023. Development of an inclusive and cost-effective Afrocentric predictive model for stroke: A novel approach.","DOI":"10.21203\/rs.3.rs-3319744\/v2"},{"key":"4833_CR35","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295\u2013300.","journal-title":"Proc R Soc Med"},{"key":"4833_CR36","unstructured":"Tenny S, Kerndt CC, Hoffman MR. Case Control Studies. 2023 Mar 27. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 28846237."},{"key":"4833_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","volume":"12","author":"KM Fedak","year":"2015","unstructured":"Fedak KM, Bernal A, Capshaw ZA, Gross S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 2015;12:14. https:\/\/doi.org\/10.1186\/s12982-015-0037-4PMID:26425136;PMCID:PMC4589117.","journal-title":"Emerg Themes Epidemiol"},{"key":"4833_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/10408444.2018.1518404","volume":"48","author":"LA Cox Jr","year":"2018","unstructured":"Cox LA Jr. Modernizing the Bradford Hill criteria for assessing causal relationships in observational data. Crit Rev Toxicol. 2018;48:682\u2013712.","journal-title":"Crit Rev Toxicol"},{"issue":"Suppl 1","key":"4833_CR39","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","volume":"95","author":"KJ Rothman","year":"2005","unstructured":"Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95(Suppl 1):S144\u201350. https:\/\/doi.org\/10.2105\/AJPH.2004.059204. (PMID: 16030331).","journal-title":"Am J Public Health"},{"issue":"10","key":"4833_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109638","volume":"9","author":"MJ Wensink","year":"2014","unstructured":"Wensink MJ, Wrycza TF, Baudisch A. Interaction Mortality: Senescence May Have Evolved because It Increases Lifespan. PLoS ONE. 2014;9(10): e109638. https:\/\/doi.org\/10.1371\/journal.pone.0109638.","journal-title":"PLoS ONE"},{"issue":"1","key":"4833_CR41","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1186\/s12879-024-10141-5","volume":"24","author":"SC Ibeneme","year":"2024","unstructured":"Ibeneme SC, Odoh E, Nweke N, Ibeneme GC. Developing an HIV-specific falls risk prediction model with a novel clinical index: a systematic review and meta-analysis method. BMC Infect Dis. 2024;24(1):1402.","journal-title":"BMC Infect Dis"},{"key":"4833_CR42","unstructured":"Nweke M, Ibeneme S, Pillay JD, Mshunqane N. Characterization and stratification risk factors of coronary artery disease in people living with PHIV: A theory-informed systematic review with epidemiological synthesis. 2025. Unpublished."},{"issue":"11","key":"4833_CR43","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1097\/QAD.0000000000003632","volume":"37","author":"M Du","year":"2023","unstructured":"Du M, Wang Y, Qin C, Mi D, Liu M, Liu J. Prevalence and incidence of stroke among people with HIV. AIDS. 2023;37(11):1747\u201356. https:\/\/doi.org\/10.1097\/QAD.0000000000003632.","journal-title":"AIDS"},{"key":"4833_CR44","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute, 2017. Available from https:\/\/reviewersmanual.joannabriggs.org\/."},{"key":"4833_CR45","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P et al. [GRADE guidelines]. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311\u20136.","DOI":"10.1016\/j.jclinepi.2011.06.004"},{"key":"4833_CR46","doi-asserted-by":"publisher","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al [GRADE guidelines]. GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407\u201315. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.017\n, PMID 21247734\n.[39].","DOI":"10.1016\/j.jclinepi.2010.07.017"},{"key":"4833_CR47","doi-asserted-by":"publisher","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al [GRADE guidelines]. GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency. J Clin Epidemiol. 2011;64(12):1294\u2013302. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.03.017\n, PMID 21803546.","DOI":"10.1016\/j.jclinepi.2011.03.017"},{"issue":"3","key":"4833_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","volume":"22","author":"MH Murad","year":"2017","unstructured":"Murad MH, Mustafa RA, Sch\u00fcnemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85\u20137.","journal-title":"Evid Based Med"},{"key":"4833_CR49","doi-asserted-by":"publisher","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al [GRADE guidelines]. GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness. J Clin Epidemiol. 2011;64(12):1303\u201310. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.04.014\n, PMID 21802903","DOI":"10.1016\/j.jclinepi.2011.04.014"},{"key":"4833_CR50","doi-asserted-by":"publisher","unstructured":"Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. RADE guidelines 6. GRADE guidelines 6. Rating the quality of evidence\u2014imprecision. J Clin Epidemiol. 2011;64(12):1283\u201393. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.01.012\n, PMID 21839614.","DOI":"10.1016\/j.jclinepi.2011.01.012"},{"key":"4833_CR51","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al [GRADE guidelines]: 5. Rating the quality of evidence\u2014publication bias. 2011;64(12):1277\u201382.","DOI":"10.1016\/j.jclinepi.2011.01.011"},{"key":"4833_CR52","unstructured":"Wilson DB. Practical Meta-Analysis Effect Size Calculator [Online calculator]. Retrieved Month Day, Year, from\u00a0https:\/\/campbellcollaboration.org\/research-resources\/effect-size-calculator.html."},{"key":"4833_CR53","doi-asserted-by":"publisher","first-page":"117955492311752","DOI":"10.1177\/11795549231175221","volume":"17","author":"TU Nwagha","year":"2023","unstructured":"Nwagha TU, Nweke M. Stratification of risk factors of lung cancer-associated venous thromboembolism and determining the critical point for preemptive intervention: A systematic review with meta-analysis. Clin Med Insights Oncol. 2023;17:11795549231175220.","journal-title":"Clin Med Insights Oncol"},{"issue":"4","key":"4833_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1212\/WNL.0000000000002278","volume":"86","author":"LA Benjamin","year":"2016","unstructured":"Benjamin LA, Corbett EL, Connor MD, Mzinganjira H, Kampondeni S, Choko A, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults A case-control study. Neurology. 2016;86(4):324\u201333. https:\/\/doi.org\/10.1212\/WNL.0000000000002278PMID26683649.","journal-title":"Neurology"},{"issue":"8","key":"4833_CR55","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/ijs.12550","volume":"10","author":"S Allie","year":"2015","unstructured":"Allie S, Stanley A, Bryer A, Meiring M, Combrinck MI. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients. Int J Stroke. 2015;10(8):1294\u20136. https:\/\/doi.org\/10.1111\/ijs.12550PMID26121272.","journal-title":"Int J Stroke"},{"issue":"5","key":"4833_CR56","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/QAI.0000000000003094","volume":"91","author":"F Chammartin","year":"2022","unstructured":"Chammartin F, Darling K, Abela IA, Battegay M, Furrer H, Calmy A, et al. CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2022;91(5):508\u201315. https:\/\/doi.org\/10.1097\/QAI.0000000000003094PMID36150371.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"4833_CR57","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1097\/01.aids.0000432457.91228.f3","volume":"27","author":"CA Sabin","year":"2013","unstructured":"Sabin CA, Ryom L, De Wit S, Mocroft A, Phillips AN, Worm SW, et al. Associations between immune depression and cardiovascular events in HIV infection. AIDS. 2013;27(17):2735\u201348. https:\/\/doi.org\/10.1097\/01.aids.0000432457.91228.f3PMID23842128.","journal-title":"AIDS"},{"issue":"13","key":"4833_CR58","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/QAD.0b013e3283493fb0","volume":"25","author":"LD Rasmussen","year":"2011","unstructured":"Rasmussen LD, Engsig FN, Christensen H, Gerstoft J, Kronborg G, Pedersen C, et al. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. AIDS. 2011;25(13):1637\u201346. https:\/\/doi.org\/10.1097\/QAD.0b013e3283493fb0PMID21646903.","journal-title":"AIDS"},{"issue":"4","key":"4833_CR59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0b013e318291cd29","volume":"63","author":"CA Sabin","year":"2013","unstructured":"Sabin CA, Ryom L, Kovari H, Kirk O, de Wit S, Law M, et al. Association between ALT level and the rate of cardio\/cerebrovascular events in HIV-positive individuals: the D:A: D Study. JAIDS J Acquir Immune Defic Syndr. 2013;63(4):456\u201363. https:\/\/doi.org\/10.1097\/QAI.0b013e318291cd29.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"3","key":"4833_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/hiv.12415","volume":"18","author":"A Silva-Pinto","year":"2017","unstructured":"Silva-Pinto A, Costa A, Serr\u00e3o R, Sarmento A, Abreu P. Ischaemic stroke in HIV-infected patients: a case-control study. HIV Med. 2017;18(3):214\u20139. https:\/\/doi.org\/10.1111\/hiv.12415PMID27535019.","journal-title":"HIV Med"},{"issue":"3","key":"4833_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/QAD.0b013e32835b2ef1","volume":"27","author":"AD Monforte","year":"2013","unstructured":"Monforte AD, Reiss P, Ryom L, El-Sadr W, Dabis F, De Wit S, et al. Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events. AIDS. 2013;27(3):407\u201315. https:\/\/doi.org\/10.1097\/QAD.0b013e32835b2ef1PMID23291539.","journal-title":"AIDS"},{"key":"4833_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.eclinm.2019.07.008","volume":"13","author":"CI Hatleberg","year":"2019","unstructured":"Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, et al. Predictors of ischemic and hemorrhagic strokes among people living with HIV: the D:A: D International prospective multicohort study. EClinicalmedicine. 2019;13:91\u2013100. https:\/\/doi.org\/10.1016\/j.eclinm.2019.07.008PMID31517266.","journal-title":"EClinicalmedicine"},{"issue":"17","key":"4833_CR63","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1097\/QAD.0000000000000452","volume":"28","author":"FC Chow","year":"2014","unstructured":"Chow FC, Bacchetti P, Kim AS, Price RW, Hsue PY. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection. AIDS. 2014;28(17):2573\u20137. https:\/\/doi.org\/10.1097\/QAD.0000000000000452PMID25160935.","journal-title":"AIDS"},{"issue":"1","key":"4833_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/QAD.0000000000001650","volume":"32","author":"FC Chow","year":"2018","unstructured":"Chow FC, Regan S, Zanni MV, Looby SE, Bushnell CD, Meigs JB, et al. Elevated ischemic stroke risk among women living with HIV infection. AIDS. 2018;32(1):59\u201367. https:\/\/doi.org\/10.1097\/QAD.0000000000001650PMID28926405.","journal-title":"AIDS"},{"issue":"9","key":"4833_CR65","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/QAD.0000000000001799","volume":"32","author":"FC Chow","year":"2018","unstructured":"Chow FC, Wilson MR, Wu KL, Ellis RJ, Bosch RJ, Linas BP. Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort. AIDS. 2018;32(9):1125\u201335. https:\/\/doi.org\/10.1097\/QAD.0000000000001799PMID29746317.","journal-title":"AIDS"},{"issue":"1","key":"4833_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/01.STR.0000105393.57853.11","volume":"35","author":"JW Cole","year":"2004","unstructured":"Cole JW, Pinto AN, Hebel JR, Buchholz DW, Earley CJ, Johnson CJ, et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke. 2004;35(1):51\u20136. https:\/\/doi.org\/10.1161\/01.STR.0000105393.57853.11PMID14684782.","journal-title":"Stroke"},{"issue":"2","key":"4833_CR67","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/09540121.2018.1510096","volume":"31","author":"J Gutierrez","year":"2019","unstructured":"Gutierrez J, Hatleberg CI, Evans H, Yin MT. Role of pre-stroke immunity in ischemic stroke mechanism among patients with HIV. AIDS Care Psychol Socio Med Aspects AIDS HIV. 2019;31(2):270\u20134. https:\/\/doi.org\/10.1080\/09540121.2018.1510096PMID30126294.","journal-title":"AIDS Care Psychol Socio Med Aspects AIDS HIV"},{"issue":"3","key":"4833_CR68","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/EDE.0000000000001331","volume":"32","author":"BN Harding","year":"2021","unstructured":"Harding BN, Avoundjian T, Heckbert SR, Whitney BM, Nance RM, Ruderman SA, et al. HIV viremia and risk of stroke among people living with HIV who are using antiretroviral therapy. Epidemiology. 2021;32(3):457\u201364. https:\/\/doi.org\/10.1097\/EDE.0000000000001331PMID33591056.","journal-title":"Epidemiology"},{"issue":"6","key":"4833_CR69","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/apc.2014.0309","volume":"29","author":"M Krsak","year":"2015","unstructured":"Krsak M, Kent DM, Terrin N, Holcroft C, Skinner SC, Wanke C. Myocardial infarction, stroke, and mortality in cART-treated HIV patients on statins. AIDS Patient Care STDs. 2015;29(6):307\u201313. https:\/\/doi.org\/10.1089\/apc.2014.0309PMID25855882.","journal-title":"AIDS Patient Care STDs"},{"issue":"6","key":"4833_CR70","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/cid\/ciad654","volume":"78","author":"MJ Vinikoor","year":"2024","unstructured":"Vinikoor MJ, Hamusonde K, Muula G, Asombang M, Riebensahm C, Chitundu H, et al. Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV\/HIV coinfection in Zambia. Clin Infect Dis. 2024;78(6):1583\u201390. https:\/\/doi.org\/10.1093\/cid\/ciad654PMID37997691.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4833_CR71","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/archneur.1997.00550210078016","volume":"54","author":"AI Qureshi","year":"1997","unstructured":"Qureshi AI, Janssen RS, Karon JM, Weissman JP, Akbar MS, Safdar K, et al. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol. 1997;54(9):1150\u20133. https:\/\/doi.org\/10.1001\/archneur.1997.00550210078016PMID9311359.","journal-title":"Arch Neurol"},{"issue":"8","key":"4833_CR72","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1056\/NEJMoa022048","volume":"348","author":"SA Bozzette","year":"2003","unstructured":"Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348(8):702\u201310. https:\/\/doi.org\/10.1056\/NEJMoa022048PMID12594314.","journal-title":"N Engl J Med"},{"key":"4833_CR73","doi-asserted-by":"publisher","unstructured":"Marconi VC, Duncan MS, So-Armah K, Lo Re VL, Lim JK, Butt AA et al. Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (veterans aging cohort study). J Am Heart Assoc. 2018;7(10). https:\/\/doi.org\/10.1161\/JAHA.117.007792\n, PMID 29720501\n.","DOI":"10.1161\/JAHA.117.007792"},{"issue":"19","key":"4833_CR74","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1212\/WNL.0000000000000958","volume":"83","author":"FC Chow","year":"2014","unstructured":"Chow FC, He W, Bacchetti P, Regan S, Feske SK, Meigs JB, et al. Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort. Neurology. 2014;83(19):1705\u201311. https:\/\/doi.org\/10.1212\/WNL.0000000000000958PMID25280902.","journal-title":"Neurology"},{"issue":"1","key":"4833_CR75","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/cid\/cir269","volume":"53","author":"RJ Bedimo","year":"2011","unstructured":"Bedimo RJ, Westfall AO, Drechsler H, Vidiella G, Tebas P. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clin Infect Dis. 2011;53(1):84\u201391. https:\/\/doi.org\/10.1093\/cid\/cir269PMID21653308.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4833_CR76","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1089\/aid.2012.0334","volume":"29","author":"MJ Vinikoor","year":"2013","unstructured":"Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY, Eron JJ. Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retroviruses. 2013;29(7):1068\u201374. https:\/\/doi.org\/10.1089\/aid.2012.0334PMID23565888.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"4833_CR77","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-023-08628-8","volume":"23","author":"HC Ku","year":"2023","unstructured":"Ku HC, Wu YL, Yip HT, Hsieh CY, Li CY, Ou HT, et al. Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: a nested case\u2013control study. BMC Infect Dis. 2023;23(1):636. https:\/\/doi.org\/10.1186\/s12879-023-08628-8PMID37770849.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4833_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151684","volume":"11","author":"YF Yen","year":"2016","unstructured":"Yen YF, Jen I, Chen M, Chuang PH, Liu YL, Sharp GB, et al. Association of cytomegalovirus end-organ disease with stroke in people living with HIV\/AIDS: A nationwide population-based cohort study. PLoS ONE. 2016;11(3): e0151684. https:\/\/doi.org\/10.1371\/journal.pone.0151684PMID26986005.","journal-title":"PLoS ONE"},{"issue":"1","key":"4833_CR79","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-021-06989-6","volume":"22","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Y, Xu QH, Zhang W, Liang HY, Wu L, et al. Stroke among highly active antiretroviral therapy-naive people living with the human immunodeficiency virus in China: a retrospective study of the characteristics, risk factors, and prognosis. BMC Infect Dis. 2022;22(1):4. https:\/\/doi.org\/10.1186\/s12879-021-06989-6PMID34983408.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4833_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/AID.2021.0046","volume":"38","author":"A Hiransuthikul","year":"2022","unstructured":"Hiransuthikul A, Chutinet A, Sophonphan J, Ubolyam S, Ruxrungtham K, Avihingsanon A, et al. Short Communication: Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: A longitudinal cohort study. AIDS Res Hum Retroviruses. 2022;38(2):131\u20134. https:\/\/doi.org\/10.1089\/AID.2021.0046PMID34714113.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"4833_CR81","doi-asserted-by":"publisher","unstructured":"Lee B, Anekthananon T, Poungvarin N, Nilanont Y. Etiology and risk factors of stroke in HIV-infected patients in Siriraj Hospital: a case-control study. J Med Assoc Thai. 2012;95;Suppl 2:S227\u201334. PMID 22574554\n.Tibekina LM, Malko VA, Flud VV, Lepilina AV. Stroke in patients with HIV infection. VI\u010c-infekc. immunosupr. 2019;11(4):51\u201360. https:\/\/doi.org\/10.22328\/2077-9828-2019-11-4-51-60\n.","DOI":"10.22328\/2077-9828-2019-11-4-51-60"},{"issue":"4","key":"4833_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.22328\/2077-9828-2019-11-4-51-60","volume":"11","author":"LM Tibekina","year":"2019","unstructured":"Tibekina LM, Malko VA, Flud VV, Lepilina AV. Stroke in patients with HIV infection. VI\u010c-infekc immunosupr. 2019;11(4):51\u201360. https:\/\/doi.org\/10.22328\/2077-9828-2019-11-4-51-60.","journal-title":"VI\u010c-infekc immunosupr"},{"issue":"4","key":"4833_CR83","first-page":"407","volume":"29","author":"MJ Feinstein","year":"2021","unstructured":"Feinstein MJ. HIV and cardiovascular disease: from insights to interventions. Top Antivir Med. 2021;29(4):407\u201311.","journal-title":"Top Antivir Med"},{"issue":"3","key":"4833_CR84","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cjca.2018.11.032","volume":"35","author":"M Bogorodskaya","year":"2019","unstructured":"Bogorodskaya M, Chow FC, Triant VA. Stroke in HIV. Can J Cardiol. 2019;35(3):280\u20137. https:\/\/doi.org\/10.1016\/j.cjca.2018.11.032.","journal-title":"Can J Cardiol"},{"issue":"12","key":"4833_CR85","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014872","volume":"98","author":"B Pan","year":"2019","unstructured":"Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M. The relationship between smoking and stroke: A meta-analysis. Medicine. 2019;98(12): e14872. https:\/\/doi.org\/10.1097\/MD.0000000000014872.","journal-title":"Medicine"},{"key":"4833_CR86","doi-asserted-by":"publisher","unstructured":"Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018:j5855\u201369. https:\/\/doi.org\/10.1136\/bmj.j5855\n.","DOI":"10.1136\/bmj.j5855"},{"issue":"7","key":"4833_CR87","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1586\/erc.10.56","volume":"8","author":"RS Shah","year":"2010","unstructured":"Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther. 2010;8(7):917\u201332. https:\/\/doi.org\/10.1586\/erc.10.56.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"4833_CR88","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11883-017-0652-3","volume":"19","author":"RP Barnes","year":"2017","unstructured":"Barnes RP, Lacson JC, Bahrami H. HIV infection and risk of cardiovascular diseases beyond coronary artery disease. Curr Atheroscler Rep. 2017;19(5):20. https:\/\/doi.org\/10.1007\/s11883-017-0652-3.","journal-title":"Curr Atheroscler Rep"},{"issue":"9","key":"4833_CR89","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1212\/WNL.0000000000200780","volume":"99","author":"C Corbett","year":"2022","unstructured":"Corbett C, Brey N, Pitcher RD, O\u2019Hagan S, Esterhuizen TM, Chow FC, et al. Prevalence and characteristics of HIV-associated stroke in a tertiary hospital setting in South Africa. Neurology. 2022;99(9):e904\u201315. https:\/\/doi.org\/10.1212\/WNL.0000000000200780.","journal-title":"Neurology"},{"issue":"11","key":"4833_CR90","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/eci.12804","volume":"47","author":"KK Olesen","year":"2017","unstructured":"Olesen KK, Madsen M, Lip GY, Egholm G, Thim T, Jensen LO, et al. Coronary artery disease and risk of adverse cardiac events and stroke. Eur J Clin Investig. 2017;47(11):819\u201328. https:\/\/doi.org\/10.1111\/eci.12804PMID28804899.","journal-title":"Eur J Clin Investig"},{"key":"4833_CR91","unstructured":"Better health channel. Heart Dis Stroke. 2014."},{"issue":"9","key":"4833_CR92","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics\u20142020 update: A report from the American Heart Association. Circulation. 2020;141(9):e139-596. https:\/\/doi.org\/10.1161\/CIR.0000000000000757.","journal-title":"Circulation"},{"issue":"3","key":"4833_CR93","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/CIRCRESAHA.120.315649","volume":"127","author":"P Libby","year":"2020","unstructured":"Libby P, Hansson GK. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2020;127(3):370\u201388. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315649.","journal-title":"Circ Res"},{"key":"4833_CR94","doi-asserted-by":"publisher","first-page":"1138234","DOI":"10.3389\/fcvm.2023.1138234","volume":"10","author":"J Yu","year":"2023","unstructured":"Yu J, Liu X, Zhu Z, Yang Z, He J, Zhang L, Lu H. Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1138234. https:\/\/doi.org\/10.3389\/fcvm.2023.1138234PMID:37034346;PMCID:PMC10077152.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"4833_CR95","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00268-006-0730-0","volume":"31","author":"H Mu","year":"2007","unstructured":"Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg. 2007;31(4):632\u201343.","journal-title":"World J Surg"},{"issue":"3","key":"4833_CR96","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/157340308785160589","volume":"4","author":"B Dau","year":"2008","unstructured":"Dau B, Holodniy M. The Relationship Between HIV Infection and Cardiovascular Disease. Curr Cardiol Rev. 2008;4(3):203\u201318. https:\/\/doi.org\/10.2174\/157340308785160589.","journal-title":"Curr Cardiol Rev"},{"key":"4833_CR97","doi-asserted-by":"crossref","unstructured":"Baker JV, Sharma S, Achhra AC, Bernardino JI, Bogner JR, Duprez D, Emery S, Gazzard B, Gordin J, Grandits G, Phillips AN, Schwarze S, Soliman EZ, Spector SA, Tambussi G, Lundgren J; INSIGHT (International Network for Strategic Initiatives in Global HIV Trials) START (Strategic Timing of Antiretroviral Treatment) Study Group. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial. J Am Heart Assoc. 2017;6(5):e004987.","DOI":"10.1161\/JAHA.116.004987"},{"issue":"1","key":"4833_CR98","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1186\/s12889-024-18672-x","volume":"24","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang J, Yang X, Gao H, Chen S, Weissman S, et al. The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study. BMC Public Health. 2024;24(1):1162. https:\/\/doi.org\/10.1186\/s12889-024-18672-xPMID38664682,PMCIDPMC11044498.","journal-title":"BMC Public Health"},{"issue":"15","key":"4833_CR99","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/ijms21155306","volume":"21","author":"S Ismael","year":"2020","unstructured":"Ismael S, Moshahid Khan M, Kumar P, Kodidela S, Mirzahosseini G, Kumar S, et al. HIV associated risk factors for ischemic stroke and future perspectives. Int J Mol Sci. 2020;21(15):5306. https:\/\/doi.org\/10.3390\/ijms21155306.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4833_CR100","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/QAD.0000000000001496","volume":"31","author":"O Putcharoen","year":"2017","unstructured":"Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, et al. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS. 2017;31(11):1535\u201343. https:\/\/doi.org\/10.1097\/QAD.0000000000001496.","journal-title":"AIDS"},{"key":"4833_CR101","doi-asserted-by":"crossref","unstructured":"Montes ML, Busca C, Espinosa N, Bernardino JI, Ibarra-Ugarte S, Mart\u00edn-Carbonero L, Moreno C, Macias J, Rivero A, Cervero-Jim\u00e9nez M, Gonz\u00e1lez-Garc\u00eda J. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile. Open Forum Infect Dis. 2024;11(4):ofae112.","DOI":"10.1093\/ofid\/ofae112"},{"key":"4833_CR102","doi-asserted-by":"crossref","unstructured":"Sabbaj-Spieler G, Overton ET, Willig A, Burkholder GA, Varshney M, Westfall AO. 344. HIV and Diabetes in the Era of Antiretroviral Therapy. Open Forum Infect Dis. 2019 ;6(Suppl 2):S183.","DOI":"10.1093\/ofid\/ofz360.417"},{"issue":"4","key":"4833_CR103","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","volume":"351","author":"R Chen","year":"2016","unstructured":"Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380\u20136. https:\/\/doi.org\/10.1016\/j.amjms.2016.01.011.","journal-title":"Am J Med Sci"},{"issue":"5","key":"4833_CR104","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","volume":"21","author":"A Poznyak","year":"2020","unstructured":"Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. https:\/\/doi.org\/10.3390\/ijms21051835PMID32155866,PMCIDPMC7084712.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4833_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-023-09815-4","volume":"24","author":"A Lembas","year":"2024","unstructured":"Lembas A, Za\u0142\u0119ski A, Peller M, Miku\u0142a T, Wierci\u0144ska-Drapa\u0142o A. Human immunodeficiency virus as a risk factor for cardiovascular disease. Cardiovasc Toxicol. 2024;24(1):1\u201314. https:\/\/doi.org\/10.1007\/s12012-023-09815-4.","journal-title":"Cardiovasc Toxicol"},{"issue":"11","key":"4833_CR106","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/jvh.12725","volume":"24","author":"O Osibogun","year":"2017","unstructured":"Osibogun O, Ogunmoroti O, Michos ED, Spatz ES, Olubajo B, Nasir K, et al. HIV\/HCV co-infection and the risk of cardiovascular disease: A meta-analysis. J Viral Hepat. 2017;24(11):998\u20131004. https:\/\/doi.org\/10.1111\/jvh.12725.","journal-title":"J Viral Hepat"},{"issue":"3","key":"4833_CR107","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3851\/IMP2724","volume":"19","author":"J Gillis","year":"2014","unstructured":"Gillis J, Smieja M, Cescon A, Rourke SB, Burchell AN, Cooper C, et al. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther. 2014;19(3):309\u201317. https:\/\/doi.org\/10.3851\/IMP2724.","journal-title":"Antivir Ther"},{"key":"4833_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6150861","volume":"2018","author":"S Drazilova","year":"2018","unstructured":"Drazilova S, Gazda J, Janicko M, Jarcuska P. Chronic hepatitis C association with diabetes mellitus and cardiovascular risk in the era of DAA therapy. Can J Gastroenterol Hepatol. 2018;2018:1\u201311. https:\/\/doi.org\/10.1155\/2018\/6150861.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"4833_CR109","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/VHRM.S53557","volume":"10","author":"T Roed","year":"2014","unstructured":"Roed T, Kristoffersen US, Knudsen A. Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C\u2014a cross-sectional study. Vasc Health Risk Manag. 2014;10:55\u201362.","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"4833_CR110","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jare.2016.06.001","volume":"8","author":"S Petta","year":"2017","unstructured":"Petta S. Hepatitis C virus and cardiovascular: a review. J Adv Res. 2017;8(2):161\u20138. https:\/\/doi.org\/10.1016\/j.jare.2016.06.001.","journal-title":"J Adv Res"},{"issue":"4","key":"4833_CR111","doi-asserted-by":"publisher","first-page":"427","DOI":"10.32598\/bcn.2021.1324.2","volume":"12","author":"A Saberi","year":"2021","unstructured":"Saberi A, Akhondzadeh S, Kazemi S, Kazemi S. Infectious agents and stroke: A systematic review. Basic Clin Neurosci. 2021;12(4):427\u201340. https:\/\/doi.org\/10.32598\/bcn.2021.1324.2.","journal-title":"Basic Clin Neurosci"},{"issue":"12","key":"4833_CR112","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1161\/STROKEAHA.123.043327","volume":"54","author":"EM Hamilton","year":"2023","unstructured":"Hamilton EM, Yang L, Wright N, Turnbull I, Mentzer AJ, Matthews PC, et al. Chronic hepatitis B virus infection and risk of stroke types: A prospective cohort study of 500 000 Chinese adults. Stroke. 2023;54(12):3046\u201353. https:\/\/doi.org\/10.1161\/STROKEAHA.123.043327.","journal-title":"Stroke"},{"issue":"35","key":"4833_CR113","doi-asserted-by":"publisher","first-page":"59658","DOI":"10.18632\/oncotarget.19609","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Xiong J, Chen X, Niu M, Chen X, Guan Y, et al. Hepatitis B virus infection and decreased risk of stroke: a meta-analysis. Oncotarget. 2017;8(35):59658\u201365. https:\/\/doi.org\/10.18632\/oncotarget.19609.","journal-title":"Oncotarget"},{"issue":"5","key":"4833_CR114","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/ane.12548","volume":"134","author":"CH Tseng","year":"2016","unstructured":"Tseng CH, Muo CH, Hsu CY, Kao CH. Association of hepatitis B virus infection with decreased ischemic stroke. Acta Neurol Scand. 2016;134(5):339\u201345. https:\/\/doi.org\/10.1111\/ane.12548.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"4833_CR115","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1572-0241.1999.00931.x","volume":"94","author":"G Marchesini","year":"1999","unstructured":"Marchesini G, Ronchi M, Forlani G, Bugianesi E, Bianchi G, Fabbri A, et al. Cardiovascular disease in cirrhosis\u2013a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol. 1999;94(3):655\u201362. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.00931.x.","journal-title":"Am J Gastroenterol"},{"key":"4833_CR116","doi-asserted-by":"crossref","unstructured":"Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatology. Baltimore; 2016. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.","DOI":"10.1002\/hep.28917"},{"issue":"6248","key":"4833_CR117","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/342440a0","volume":"342","author":"T Nakamura","year":"1989","unstructured":"Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342(6248):440\u20133. https:\/\/doi.org\/10.1038\/342440a0.","journal-title":"Nature"},{"issue":"1","key":"4833_CR118","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.1840210119","volume":"21","author":"G Shiota","year":"1995","unstructured":"Shiota G, Okano JI, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology. 1995;21(1):106\u201312. https:\/\/doi.org\/10.1002\/hep.1840210119.","journal-title":"Hepatology"},{"issue":"5\u20136","key":"4833_CR119","first-page":"315","volume":"69","author":"J Ly","year":"2014","unstructured":"Ly J, Maquet P. Accident vasculaire c\u00e9r\u00e9bral du sujet \u00e2g\u00e9 [Stroke and aging]. Rev Med Li\u00e8ge. 2014;69(5\u20136):315\u20137.","journal-title":"Rev Med Li\u00e8ge"},{"issue":"9","key":"4833_CR120","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.18632\/aging.101931","volume":"11","author":"M Yousufuddin","year":"2019","unstructured":"Yousufuddin M, Young N. Aging and ischemic stroke. Aging. 2019;11(9):2542\u20134. https:\/\/doi.org\/10.18632\/aging.101931.","journal-title":"Aging"},{"issue":"12","key":"4833_CR121","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics\u20142018 Update: a Report From the American Heart Association. Circulation. 2018;137(12):e67-492. https:\/\/doi.org\/10.1161\/CIR.0000000000000558.","journal-title":"Circulation"},{"issue":"4","key":"4833_CR122","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3390\/jcm9041234","volume":"9","author":"L Fauchier","year":"2020","unstructured":"Fauchier L, Bodin A, Bisson A, Herbert J, Spiesser P, Clementy N, et al. Incident comorbidities, aging and the risk of stroke in 608,108 patients with atrial fibrillation: A nationwide analysis. J Clin Med. 2020;9(4):1234. https:\/\/doi.org\/10.3390\/jcm9041234.","journal-title":"J Clin Med"},{"issue":"2","key":"4833_CR123","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","volume":"71","author":"TF Chao","year":"2018","unstructured":"Chao TF, Lip GY, Liu CJ, Lin YJ, Chang SL, Lo LW, et al. Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71(2):122\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.085.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4833_CR124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874613601509010051","volume":"9","author":"DS Nsagha","year":"2015","unstructured":"Nsagha DS, Assob JC, Njunda AL, Tanue EA, Kibu OD, Ayima CW, et al. Risk factors of cardiovascular diseases in HIV\/AIDS patients on HAART. Open AIDS J. 2015;9(1):51\u20139. https:\/\/doi.org\/10.2174\/1874613601509010051.","journal-title":"Open AIDS J"},{"key":"4833_CR125","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95\u20139. https:\/\/doi.org\/10.1016\/j.phrs.2017.11.003.","journal-title":"Pharmacol Res"},{"key":"4833_CR126","unstructured":"Tackling G, Borhade MB; Updated 2023 Jun 26. Hypertensive Heart Disease. In: StatPearls [Internet]. Treasure Island, (FL): StatPearls Publishing; 2024 Jan-.\u00a0Available. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539800\/."},{"key":"4833_CR127","doi-asserted-by":"crossref","unstructured":"Hatleberg CI, Ryom L, d'Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. HIV Med. 2018;19(9):605\u2013618.","DOI":"10.1111\/hiv.12639"},{"issue":"5","key":"4833_CR128","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/QAI.0000000000002598","volume":"86","author":"HM Crane","year":"2021","unstructured":"Crane HM, Nance RM, Avoundjian T, Harding BN, Whitney BM, Chow FC, et al. Types of stroke among people living with HIV in the United States. J Acquir Immune Defic Syndr. 2021;86(5):568\u201378. https:\/\/doi.org\/10.1097\/QAI.0000000000002598.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"4833_CR129","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/QAD.0b013e328352ce54","volume":"26","author":"JE Ho","year":"2012","unstructured":"Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, et al. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS (Lond Engl). 2012;26(9):1115\u201320. https:\/\/doi.org\/10.1097\/QAD.0b013e328352ce54.","journal-title":"AIDS (Lond Engl)"},{"issue":"17","key":"4833_CR130","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1097\/QAD.0000000000002010","volume":"32","author":"H Roul","year":"2018","unstructured":"Roul H, Mary-Krause M, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, et al. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era. AIDS. 2018;32(17):2605\u201314. https:\/\/doi.org\/10.1097\/QAD.0000000000002010.","journal-title":"AIDS"},{"issue":"8","key":"4833_CR131","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/QAD.0000000000001801","volume":"32","author":"S Kroeze","year":"2018","unstructured":"Kroeze S, Ondoa P, Kityo CM, Siwale M, Akanmu S, Wellington M, et al. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. AIDS. 2018;32(8):1043\u201351. https:\/\/doi.org\/10.1097\/QAD.0000000000001801.","journal-title":"AIDS"},{"issue":"1","key":"4833_CR132","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/524143","volume":"197","author":"PW Hunt","year":"2008","unstructured":"Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197(1):126\u201333. https:\/\/doi.org\/10.1086\/524143.","journal-title":"J Infect Dis"},{"issue":"1","key":"4833_CR133","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.122.057443","volume":"147","author":"M Ntsekhe","year":"2023","unstructured":"Ntsekhe M, Baker JV. Cardiovascular disease among persons living with HIV: new insights into pathogenesis and clinical manifestations in a global context. Circulation. 2023;147(1):83\u2013100. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.057443.","journal-title":"Circulation"},{"issue":"17","key":"4833_CR134","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jacc.2022.08.756","volume":"80","author":"S Kundu","year":"2022","unstructured":"Kundu S, Freiberg MS, Tracy RP, So-Armah KA, Koethe JR, Duncan MS, et al. Circulating T cells and cardiovascular risk in people with and without HIV infection. J Am Coll Cardiol. 2022;80(17):1633\u201344. https:\/\/doi.org\/10.1016\/j.jacc.2022.08.756.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4833_CR135","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1570162X17666191212091618","volume":"18","author":"M Grand","year":"2020","unstructured":"Grand M, Bia D, Diaz A. Cardiovascular risk assessment in people living with HIV: a systematic review and meta-analysis of real-life data. Curr HIV Res. 2020;18(1):5\u201318. https:\/\/doi.org\/10.2174\/1570162X17666191212091618.","journal-title":"Curr HIV Res"},{"issue":"9943","key":"4833_CR136","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)61177-6.","journal-title":"Lancet"},{"key":"4833_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/714653","volume":"2013","author":"G Maiolino","year":"2013","unstructured":"Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP, Cal\u00f2 LA. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflam. 2013;2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/714653.","journal-title":"Mediators Inflam"},{"issue":"1","key":"4833_CR138","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcmm.12689","volume":"20","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov DA, Bobryshev YV, Orekhov AN. Macrophage-mediated cholesterol handling in atherosclerosis. J Cell Mol Med. 2016;20(1):17\u201328. https:\/\/doi.org\/10.1111\/jcmm.12689.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4833_CR139","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cid\/ciy146","volume":"67","author":"M Gelpi","year":"2018","unstructured":"Gelpi M, Afzal S, Lundgren J, Ronit A, Roen A, Mocroft A, et al. Higher risk of abdominal obesity, elevated low-density lipoprotein cholesterol, and hypertriglyceridemia, but not of hypertension, in people living with human immunodeficiency virus (HIV): results from the Copenhagen comorbidity in HIV infection study. Clin Infect Dis. 2018;67(4):579\u201386. https:\/\/doi.org\/10.1093\/cid\/ciy146.","journal-title":"Clin Infect Dis"},{"key":"4833_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-020-1273-y","volume":"22","author":"AK Dwivedi","year":"2020","unstructured":"Dwivedi AK, Dubey P, Cistola DP, Reddy SY. Association between obesity and cardiovascular outcomes: updated evidence from meta-analysis studies. Curr Cardiol Rep. 2020;22:1\u20139.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"4833_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/535918","volume":"2010","author":"Z Wang","year":"2010","unstructured":"Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflam. 2010;2010(1):1\u201317. https:\/\/doi.org\/10.1155\/2010\/535918.","journal-title":"Mediators Inflam"},{"issue":"3","key":"4833_CR142","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ecl.2008.06.005","volume":"37","author":"GM Reaven","year":"2008","unstructured":"Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am. 2008;37(3):581\u2013601. https:\/\/doi.org\/10.1016\/j.ecl.2008.06.005.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7121","key":"4833_CR143","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875\u201380. https:\/\/doi.org\/10.1038\/nature05487.","journal-title":"Nature"},{"issue":"6","key":"4833_CR144","first-page":"479","volume":"41","author":"NE Kelso","year":"2015","unstructured":"Kelso NE, Sheps DS, Cook RL. The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review. Am J Drug Alcohol Abuse. 2015;41(6):479\u201388.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"4833_CR145","unstructured":"Chichetto NE.\u00a0Alcohol Consumption among Persons Living with HIV: Patterns and Determinants of Use and Impact on Subclinical Cardiovascular Disease\u00a0(Doctoral dissertation, University of Florida)."},{"key":"4833_CR146","unstructured":"Center for Disease and Control (CDC). Alcohol use; May 2024. Available from: https:\/\/www.cdc.gov\/alcohol\/index.html."},{"issue":"7","key":"4833_CR147","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1532-5415.1999.tb03844.x","volume":"47","author":"MC Reid","year":"1999","unstructured":"Reid MC, Concaio J, Towle VR, Williams CS, Tinetti ME. Alcohol use and functional disability among cognitively impaired adults. J Am Geriatr Soc. 1999;47(7):854\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.1999.tb03844.x.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"4833_CR148","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s40429-016-0124-9","volume":"3","author":"RC Reid","year":"2016","unstructured":"Reid RC, Meyer MD. Substance use disorders in hypersexual adults. Curr Addict Rep. 2016;3(4):400\u20135. https:\/\/doi.org\/10.1007\/s40429-016-0124-9.","journal-title":"Curr Addict Rep"},{"issue":"2","key":"4833_CR149","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/QAI.0b013e3181c6c4b7","volume":"53","author":"MS Freiberg","year":"2010","unstructured":"Freiberg MS, McGinnis KA, Kraemer KMD, Samet JH, Conigliaro J, Ellison CR, Bryant K, Kuller LH, Justice AC. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2010;53(2):247\u201353. https:\/\/doi.org\/10.1097\/QAI.0b013e3181c6c4b7.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"4833_CR150","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012241","volume":"8","author":"A Alonso","year":"2019","unstructured":"Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. 2019;8(14): e012241. https:\/\/doi.org\/10.1161\/JAHA.119.012241.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4833_CR151","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","volume":"20","author":"L Di Lullo","year":"2015","unstructured":"Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C. Chronic kidney disease and cardiovascular complications. Heart Fail Rev. 2015;20(3):259\u201372. https:\/\/doi.org\/10.1007\/s10741-014-9460-9.","journal-title":"Heart Fail Rev"},{"issue":"11","key":"4833_CR152","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686.","journal-title":"Circulation"},{"key":"4833_CR153","unstructured":"Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19)."},{"issue":"3","key":"4833_CR154","doi-asserted-by":"publisher","first-page":"99","DOI":"10.12860\/jnp.2014.19","volume":"3","author":"S Said","year":"2014","unstructured":"Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3(3):99\u2013104. https:\/\/doi.org\/10.12860\/jnp.2014.19.","journal-title":"J Nephropathol"},{"key":"4833_CR155","doi-asserted-by":"publisher","unstructured":"Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354. https:\/\/doi.org\/10.1136\/bmj.i4482\n.","DOI":"10.1136\/bmj.i4482"},{"issue":"19","key":"4833_CR156","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","volume":"106","author":"WY Ding","year":"2020","unstructured":"Ding WY, Gupta D, Lip GY. Atrial fibrillation and the prothrombotic state: revisiting Virchow\u2019s triad in 2020. Heart. 2020;106(19):1463\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2020-316977.","journal-title":"Heart"},{"key":"4833_CR157","doi-asserted-by":"publisher","unstructured":"Lip GY, Proietti M, Potpara T, Mansour M, Savelieva I, Tse HF et al. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace Eur Pacing Arrhythmias Card Electrophysiol J Working Groups Card Pacing Arrhythmias Card Cell Electrophysiol Eur Soc Cardiol. 2023;25(9):euad226. https:\/\/doi.org\/10.1093\/europace\/euad226\n.","DOI":"10.1093\/europace\/euad226"},{"issue":"8","key":"4833_CR158","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93\u2013621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123PMID36695182.","journal-title":"Circulation"},{"key":"4833_CR159","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-444-63849-6.00015-3","volume":"152","author":"L Benjamin","year":"2018","unstructured":"Benjamin L, Khoo S. HIV infection and stroke. Handb Clin Neurol. 2018;152:187\u2013200. https:\/\/doi.org\/10.1016\/B978-0-444-63849-6.00015-3.","journal-title":"Handb Clin Neurol"},{"key":"4833_CR160","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.hjc.2022.12.013","volume":"71","author":"PC Fragkou","year":"2023","unstructured":"Fragkou PC, Moschopoulos CD, Dimopoulou D, Triantafyllidi H, Birmpa D, Benas D, et al. Cardiovascular disease and risk assessment in people living with HIV: current practices and novel perspectives. Hellenic J Cardiol. 2023;71:42\u201354. https:\/\/doi.org\/10.1016\/j.hjc.2022.12.013.","journal-title":"Hellenic J Cardiol"},{"issue":"9","key":"4833_CR161","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816PMID26192873,PMCIDPMC4569751.","journal-title":"N Engl J Med"},{"issue":"2","key":"4833_CR162","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pcad.2020.01.006","volume":"63","author":"I Nguyen","year":"2020","unstructured":"Nguyen I, Kim AS, Chow FC. Prevention of stroke in people living with HIV. Prog Cardiovasc Dis. 2020;63(2):160\u20139. https:\/\/doi.org\/10.1016\/j.pcad.2020.01.006PMID32014514.","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"4833_CR163","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","volume":"165","author":"FJT Brown","year":"2005","unstructured":"Brown FJT, Cole TX, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165(10):1179\u201384. https:\/\/doi.org\/10.1001\/archinte.165.10.1179.","journal-title":"Arch Intern Med"},{"issue":"7","key":"4833_CR164","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.02.016","volume":"27","author":"A Abdallah","year":"2018","unstructured":"Abdallah A, Chang JL, O\u2019Carroll CB, Musubire A, Chow FC, Wilson AL, Siedner MJ. Stroke in human immunodeficiency virus-infected individuals in Sub-Saharan Africa (SSA): a systematic review. J Stroke Cerebrovasc Dis. 2018;27(7):1828\u201336.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"4833_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208040","volume":"13","author":"J Kamtchum-Tatuene","year":"2018","unstructured":"Kamtchum-Tatuene J, Al-Bayati Z, Mwandumba HC, Solomon T, Christmas SE, Benjamin LA. Serum concentration of anti-cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi. PLoS ONE. 2018;13(11): e0208040. https:\/\/doi.org\/10.1371\/journal.pone.0208040.","journal-title":"PLoS ONE"},{"issue":"7","key":"4833_CR166","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/605578","volume":"49","author":"AC Ross","year":"2009","unstructured":"Ross AC, Rizk N, O\u2019Riordan MA, Dogra V, El-Bejjani D, Storer N, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;49(7):1119\u201327. https:\/\/doi.org\/10.1086\/605578.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4833_CR167","doi-asserted-by":"crossref","unstructured":"Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M; et al. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. Lancet HIV. 2018;5(6):e291\u2013300.","DOI":"10.1016\/S2352-3018(18)30043-2"},{"issue":"14","key":"4833_CR168","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/QAD.0000000000000762","volume":"29","author":"JH Stein","year":"2015","unstructured":"Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, et al. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS (Lond Engl). 2015;29(14):1775\u201383. https:\/\/doi.org\/10.1097\/QAD.0000000000000762.","journal-title":"AIDS (Lond Engl)"},{"key":"4833_CR169","doi-asserted-by":"publisher","unstructured":"Bavinger C, Bendavid E, Niehaus K, Olshen RA, Olkin I, Sundaram V; et al. Risk of cardiovascular disease from antiretroviral therapy for HIV: A systematic review. PLOS ONE. 2013;8(3). https:\/\/doi.org\/10.1371\/journal.pone.0059551\n.","DOI":"10.1371\/journal.pone.0059551"},{"issue":"2","key":"4833_CR170","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","volume":"140","author":"MJ Feinstein","year":"2019","unstructured":"Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: A scientific statement from the American Heart Association. Circulation. 2019;140(2):e98\u2013124. https:\/\/doi.org\/10.1161\/CIR.0000000000000695.","journal-title":"Circulation"},{"key":"4833_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109132","volume":"229","author":"WQ Gan","year":"2021","unstructured":"Gan WQ, Buxton JA, Scheuermeyer FX, Palis H, Zhao B, Desai R, et al. Risk of cardiovascular diseases in relation to substance use disorders. Drug Alcohol Depend. 2021;229: 109132. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109132.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"4833_CR172","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27016","volume":"14","author":"N Chelikam","year":"2022","unstructured":"Chelikam N, Vyas V, Dondapati L, Iskander B, Patel G, Jain S, et al. Epidemiology, burden, and association of substance abuse amongst patients with cardiovascular disorders: national cross-sectional survey study. Cureus. 2022;14(7): e27016. https:\/\/doi.org\/10.7759\/cureus.27016PMID35989848.","journal-title":"Cureus"},{"issue":"3","key":"4833_CR173","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/ijms20030584","volume":"20","author":"ST Kim","year":"2019","unstructured":"Kim ST, Park T. Acute and chronic effects of cocaine on cardiovascular health. Int J Mol Sci. 2019;20(3):584. https:\/\/doi.org\/10.3390\/ijms20030584PMID30700023.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4833_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235821","volume":"15","author":"CA Basham","year":"2020","unstructured":"Basham CA, Smith SJ, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PLoS ONE. 2020;15(7): e0235821. https:\/\/doi.org\/10.1371\/journal.pone.0235821.","journal-title":"PLoS ONE"},{"issue":"4","key":"4833_CR175","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","volume":"60","author":"FC Chow","year":"2012","unstructured":"Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012;60(4):351\u20138. https:\/\/doi.org\/10.1097\/QAI.0b013e31825c7f24PMID22580566.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"4833_CR176","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1161\/STROKEAHA.122.039484","volume":"53","author":"HR Lee","year":"2022","unstructured":"Lee HR, Yoo JE, Choi H, Han K, Jung JH, Park J, et al. Tuberculosis and risk of ischemic stroke: A nationwide cohort study. Stroke. 2022;53(11):3401\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.122.039484.","journal-title":"Stroke"},{"key":"4833_CR177","unstructured":"Mengistu AD. The intersection of tuberculosis and cardiovascular disease: a systematic review. Ethiop Med J. 2019;57(3)."},{"key":"4833_CR178","doi-asserted-by":"publisher","first-page":"1364337","DOI":"10.3389\/fcvm.2024.1364337","volume":"11","author":"J Yang","year":"2024","unstructured":"Yang J, Kim SH, Sim JK, Gu S, Seok JW, Bae DH, et al. Tuberculosis survivors and the risk of cardiovascular disease: analysis using a nationwide survey in Korea. Front Cardiovasc Med. 2024;11:1364337. https:\/\/doi.org\/10.3389\/fcvm.2024.1364337.","journal-title":"Front Cardiovasc Med"},{"key":"4833_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40794-015-0014-5","volume":"1","author":"MA Huaman","year":"2015","unstructured":"Huaman MA, Henson D, Ticona E, Sterling TR, Garvy BA. Tuberculosis and cardiovascular disease: linking the epidemics. Trop Dis Travel Med Vaccines. 2015;1:1\u20137. https:\/\/doi.org\/10.1186\/s40794-015-0014-5PMID26835156.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"4833_CR180","doi-asserted-by":"publisher","unstructured":"Yang J, Kim SH, Sim JK, Gu S, Seok JW, Bae DH et al. Tuberculosis survivors and the risk of cardiovascular disease: analysis using a nationwide survey in Korea. Front Cardiovasc Med. 1st version available at Research Square. Oct\u00a019 2023 [preprint];11. https:\/\/doi.org\/10.21203\/rs.3.rs-3451909\/v1\n.","DOI":"10.21203\/rs.3.rs-3451909\/v1"},{"key":"4833_CR181","unstructured":"World Health Organization. HIV and AIDS; Jul\u00a022 2024."},{"key":"4833_CR182","doi-asserted-by":"publisher","unstructured":"Kovacs L, Kress TC, Belin de Chantem\u00e8le EJ. HIV, combination antiretroviral therapy, and vascular diseases in men and women. Basic Transl Sci. 2022;7(4):410\u201321. https:\/\/doi.org\/10.1016\/j.jacbts.2021.10.017\n.","DOI":"10.1016\/j.jacbts.2021.10.017"},{"key":"4833_CR183","doi-asserted-by":"publisher","unstructured":"O\u2019Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H et al., \u2026 INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet (London, England). 2016;388(10046):761\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(16)30506-2\n.","DOI":"10.1016\/S0140-6736(16)30506-2"},{"issue":"4","key":"4833_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107624","volume":"33","author":"M Hanna","year":"2024","unstructured":"Hanna M, Wabnitz A, Grewal P. Sex and stroke risk factors: a review of differences and impact. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2024;33(4): 107624. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.107624.","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"issue":"4","key":"4833_CR185","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.121.319915","volume":"130","author":"KM Rexrode","year":"2022","unstructured":"Rexrode KM, Madsen TE, Yu AY, Carcel C, Lichtman JH, Miller EC. The impact of sex and gender on stroke. Circ Res. 2022;130(4):512\u201328. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319915.","journal-title":"Circ Res"},{"issue":"1","key":"4833_CR186","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/QAD.0000000000000875","volume":"30","author":"FC Chow","year":"2016","unstructured":"Chow FC, Boscardin WJ, Mills C, Ko N, Carroll C, Price RW, et al. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals. AIDS (Lond Engl). 2016;30(1):45\u201355. https:\/\/doi.org\/10.1097\/QAD.0000000000000875PMID26372478.","journal-title":"AIDS (Lond Engl)"},{"issue":"12","key":"4833_CR187","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1212\/WNL.0000000000000237","volume":"82","author":"J Gutierrez","year":"2014","unstructured":"Gutierrez J, Williams OA. A decade of racial and ethnic stroke disparities in the United States. Neurology. 2014;82(12):1080\u20132. https:\/\/doi.org\/10.1212\/WNL.0000000000000237.","journal-title":"Neurology"},{"key":"4833_CR188","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2022.06.001","volume":"353","author":"F Fogacci","year":"2022","unstructured":"Fogacci F, Borghi C, Grassi D, Cicero AFG. People living with human immunodeficiency virus: Cardiovascular risk screening for an early and effective risk management. Atherosclerosis. 2022;353:28\u20139.","journal-title":"Atherosclerosis"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04833-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04833-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04833-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:02:47Z","timestamp":1748372567000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04833-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":188,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04833-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}